DCLT yields 2000000.00% · JNJ yields 2.13%● Live data
📍 DCLT pulled ahead of the other in Year 1
Combined, DCLT + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of DCLT + JNJ for your $10,000?
Data Call Technologies, Inc. provides real-time information/content through digital signage and kiosk networks in the United States. The company's software and services enable clients to have control of real-time advertising, news, and other content, including emergency alerts. Its data and information types comprise world and national news headlines, business and entertainment headlines, world-based financial indicators, science/health news, latest off-beat news headlines, sports headlines, sports odds for NFL, NBA, NHL, NCAA football and basketball, various game schedules and in-game updates, professional golf association, NASCAR top 10 race positions, traffic mapping, animated Doppler radar and forecast maps, listings of the day's horoscopes and birthdays, health and wellness, listings of historical events that occurred on each day in history, and localized traffic and weather forecasts. It offers its products and services through the Internet. The company was formerly known as Data Call Wireless, Inc. and changed its name to Data Call Technologies, Inc. in March 2006. Data Call Technologies, Inc. was incorporated in 2002 and is based in Friendswood, Texas.
Full DCLT Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.